期刊文献+

EGFR-TKI治疗后非小细胞肺癌中医证候研究 被引量:27

Study on Distribution of Traditional Chinese Medicine Syndromes of NSCLC after EGFR-TKI Treatment
原文传递
导出
摘要 目的观察靶向药物治疗后非小细胞肺癌(NSCLC)患者的中医证候分布。方法采用临床流行病学调查方法观察506例表皮生长因子受体酪氨酸激酶阻滞剂(EGFR-TKI)治疗后的NSCLC患者症状、体征、舌脉四诊资料,运用聚类分析方法观察靶向药物治疗后NSCLC患者的中医证候特征规律,进行因子分析,观察各个证型辨证的主次症。结果患者中医证型主要为肺阴亏虚证(281例,55.53%)、气阴两虚证(145例,28.66%)、肺脾气虚证(80例,15.81%)。肺阴亏虚证主要证素为咳嗽、痰少、痰黏、皮疹瘙痒、皮肤干燥、口干渴、舌红、裂纹舌、脉细;次症为苔薄或苔白(P=0.001)。气阴两虚证主要证素为头晕、口干不欲饮、脉弱、少寐;次症为气促、干咳无痰、咽干、心烦(P=0.001)。肺脾气虚证主要证素为神疲乏力、恶心、纳差、大便不成形、舌淡红、苔腻、胖大齿痕舌、脉滑;次症为面萎黄或胸闷(P=0.001)。结论靶向药物治疗后NSCLC患者的证型主要为肺阴亏虚证、气阴两虚证和肺脾气虚证,其核心证型是肺阴亏虚证。 Objective To observe the distribution of Chinese Medicine( CM) syndromes in patients with non-small cell lung cancer( NSCLC) after EGFR-TKIs treatment. Methods The clinical materials,including symptoms,signs,and manifestations of tongue and pulse,were investigated in 506 NSCLC patients by using clinical epidemiological method after EGFR-TKIs,and then the characteristics of CM syndromes in NSCLC patients after EGFR-TKIs treatment were explored by cluster analysis. On the basis of the cluster analysis the primary and secondary symptoms of each syndrome were identified preliminarily by factor analysis. Result Fei-yin deficiency syndrome( 281 cases,55. 53%),qi-yin deficiency syndrome( 145 cases,28. 66%),Fei-Pi qi deficiency syndrome( 80 cases,15. 81%) were the main CM syndrome types of NSCLC patients after EGFR-TKIs treatment. The primary syndrome elements of Fei-yin deficiency syndrome were cough,less sputum,sticky sputum,skin rash,itching,dry skin,thirst,red tongue,fissured tongue,thin pulse. Secondary symptoms was thin lingual fur or white lingual fur(P = 0. 001). Qi-yin deficiency syndrome differentiation basis for dizziness,dry mouth,weak pulse,little sleep.Secondary symptoms were anhelation,hoose,dry pharynx,vexation(P = 0. 001). The primary syndrome elements of Fei-Pi qi deficiency were lassitude,nausea,anorexia,loose stool,teeth-marked tongue,slippery pulse. Secondary symptoms were sallow complexion or chest tightness(P = 0. 001). Conclusion The main syndromes of patients with NSCLC after EGFR-TKIs treatment were Fei-yin deficiency syndrome,qi-yin deficiency syndrome,Fei-Pi qi deficiency syndrome,and the core syndrome was Fei-yin deficiency.
出处 《中国中西医结合杂志》 CAS CSCD 北大核心 2017年第9期1050-1053,共4页 Chinese Journal of Integrated Traditional and Western Medicine
基金 国家自然科学基金委员会资助项目(No.81573890) 上海市进一步加快中医药事业发展三年行动计划(No.CCCX-3-3001) 国家中医药管理局中医临床研究基地业务建设科研专项课题(No.JDZX2015069) 龙华医院第三批中青年名中医培养计划(No.RC-2017-01-10)
关键词 表皮生长因子受体激酶酪氨酸阻滞剂 非小细胞肺癌 中医证候 聚类分析 因子分析 sepidermal growth factor receptor tyrosine kinase inhibitors non-small cell lung cancer Chinese medicine syndrome cluster analysis factor analysis
  • 相关文献

参考文献7

二级参考文献55

  • 1方肇勤.中医辨证标准制定的若干关键问题[J].上海中医药杂志,2006,40(1):11-13. 被引量:22
  • 2尤建良.晚期肺癌治疗经验[J].时珍国医国药,2007,18(1):205-207. 被引量:10
  • 3唐功爽.基于SPSS的主成分分析与因子分析的辨析[J].统计教育,2007(2):12-14. 被引量:66
  • 4沈自尹 王文健.中医虚证辨证参考标准[J].中西医结合杂志,1986,6(10):598-598.
  • 5国家技术监督局.中医临床诊疗术语[M].北京:中国标准出版社,1997.7.
  • 6胡成平.吉非替尼在晚期非小细胞肺癌治疗中的地位.Chest中文版,2005,12(6):3975-3984.
  • 7Fukuoka M, Yano S, Giaccone G, et al.Multi-institutional randomized phase Ⅱ trial of gefitinib for previously treated patients with advanced non-snmll cell lung cancer [J] . J Clin Oncol, 2003, 21 (12): 2237 - 2246.
  • 8KrisMG, NataleRB, HerbstRS, etal. Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non - small cell lung cancer: a randomized trial [J] .J Am Med Assoc, 2003, 290 (16) : 2149- 2158.
  • 9冷方南.中医证候辨治轨范[M].北京:人民卫生出版社,1989,3..
  • 10朱文峰.中医内科疾病诊疗常规[M].长沙:湖南科技出版社,1999.316.

共引文献437

同被引文献406

引证文献27

二级引证文献146

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部